Lipomedix Pharmaceuticals Inc.   Report issue

For profit Phase 1
Founded: Jerusalem Israel (2011)

Organization Overview

First Clinical Trial
2012
NCT01705002
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Lipomedix Pharmaceuticals Inc.